Showing results (1351-1360 of 2,158) with videos related to
Sort By:
Pageof 216
Journal of Biopharmaceutical Statistics|April 23, 2009
Optimal two-stage randomized multinomial designs for Phase II oncology trialsLinda Z Sun, Cong Chen, Kamlesh PatelJournal of Biopharmaceutical Statistics|April 23, 2009
Selecting promising treatments in randomized Phase II cancer trials with an active controlYing Kuen CheungJournal of Biopharmaceutical Statistics|September 11, 2008
Estimation of lag time between onset of and death from an occult tumorHongshik Ahn, Hojin Moon, Ralph L KodellJournal of Biopharmaceutical Statistics|September 11, 2008
Proof of hazard and proof of safety in toxicological studies using simultaneous confidence intervals for differences and ratios to controlLudwig A Hothorn, Mario HaslerJournal of Biopharmaceutical Statistics|September 11, 2008
A comparison of false positive rates of peto and poly-3 methods for long-term carcinogenicity data analysis using multiple comparison adjustment method suggested by Lin and RahmanMohammad A Rahman, Karl K LinJournal of Biopharmaceutical Statistics|September 11, 2008
Statistical assessment of analytical method transferJinglin Zhong, Kathy Lee, Yi TsongJournal of Biopharmaceutical Statistics|February 13, 2009
An adaptive first in man dose-escalation study of NGX267: statistical, clinical, and operational considerationsAnastasia Ivanova, Michael MurphyJournal of Biopharmaceutical Statistics|February 13, 2009
On identifying effective and superior drug combinations via Holm's procedure based on the min testsJulia N SoulakovaJournal of Biopharmaceutical Statistics|February 13, 2009
Balanced 2(n) factorial designs when observations are spatially correlatedVenkat Sethuraman, Damaraju RaghavaraoJournal of Biopharmaceutical Statistics|February 13, 2009
Optimal design criteria for discrimination and estimation in nonlinear modelsT H Waterhouse, J A Eccleston, S B DuffullPageof 216